News

The Food and Drug Administration today recommended medical device manufacturers, health care providers and patients take certain actions to reduce the risk that a remote attacker could exploit a set of cybersecurity vulnerabilities to control a medical device or prevent it from functioning.

States can apply to participate in an Affordable Care Act demonstration program to implement wellness programs in their individual health insurance market, the Centers for Medicare & Medicaid Services announced yesterday.

The Medicare Shared Savings Program generated $739.4 million in total net savings across 548 accountable care organizations in 2018, Centers for Medicare & Medicaid Services Administrator Seema Verma announced yesterday.

The Department of Health and Human Services through June 30 has reduced by 25% its backlog of Medicare appeals at the Administrative Law Judge level, according to a status report the agency recently provided to a federal court.

President Trump Friday signed a continuing resolution that funds the federal government through Nov. 21 and delays impending Medicaid cuts, among other provisions.

The Food and Drug Administration last week updated 2017 draft guidance to clarify the categories of clinical and decision support software subject to FDA oversight under the 21st Century Cures Act based on risk.

Nearly one in 10 Medicare enrollees aged 65 or older, and four in 10 younger Medicare enrollees with long-term disabilities, experience food insecurity, according to a study reported today.

While each hospital and health system has their own priorities and challenges, our mission as caregivers is the same: To advance the health of individuals and communities. Learning from each other is a great way to achieve that goal.

CMS’ proposal mandating the disclosure of negotiated charges between health plans and hospitals is the wrong approach, exceeds the Administration's legal authority and should be abandoned, AHA told the agency today.

The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act, H.R. 4538, bipartisan legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals.